How AI Infrastructure and Digital Pathology Are Transforming Clinical Diagnosis

Introduction

Artificial intelligence is reshaping the future of pathology. However, successful AI deployment requires much more than advanced algorithms. Hospitals also need reliable computing resources, standardized digital workflows, and high-quality whole slide images.

As pathology departments process more cases each year, diagnostic complexity continues to increase. Meanwhile, pathologists face growing workloads and rising quality requirements. Therefore, healthcare organizations are looking for practical AI solutions that improve efficiency without compromising diagnostic accuracy.

A recent collaboration between KFBIO (Konfoong Bioinformation Tech Co., Ltd) and Zhongshan Hospital, Fudan University, provides an excellent example of this transformation. Together, they established a trusted AI computing platform for pathology that combines secure data management, AI model development, clinical validation, and continuous optimization. The project demonstrated that domestic AI computing achieved nearly 90% of NVIDIA H100 computing performance at approximately one-sixth of the cost, creating a scalable and cost-effective foundation for pathology AI.

While the computing platform is central to this case, it also highlights a broader industry trend. AI delivers its greatest value when it is integrated into a complete digital pathology ecosystem. High-quality image acquisition, standardized workflows, and efficient data management are equally important for successful AI deployment.

This is where KFBIO’s end-to-end digital pathology solutions play an important role. By combining advanced Digital Pathology Scanners, Whole Slide Imaging (WSI) technology, intelligent image management, and AI-ready workflow solutions, KFBIO helps hospitals build scalable digital pathology platforms that support both current clinical needs and future AI innovation.

Why Pathology Needs AI More Than Ever

Digital pathology has become a key driver of modern precision medicine. Every day, pathology laboratories generate thousands of high-resolution whole slide images. As image volumes continue to grow, manual review becomes increasingly time-consuming.

At the same time, hospitals face several operational challenges:

• Increasing pathology case volumes
• More complex disease classification
• Higher quality assurance standards
• A global shortage of experienced pathologists
• Faster turnaround time requirements

Consequently, pathology departments must improve efficiency while maintaining diagnostic quality.

Traditional pathology workflows rely heavily on manual slide review. Although experienced pathologists remain essential, manual screening alone cannot always meet today’s clinical demands. AI-assisted pathology provides an effective way to reduce repetitive work, prioritize suspicious cases, and improve overall workflow efficiency.

Instead of replacing pathologists, AI acts as an intelligent assistant. It rapidly identifies areas of interest, highlights potential abnormalities, and supports structured reporting. As a result, pathologists can focus more attention on complex cases that require professional judgment.

The Foundation of AI Is Digital Pathology

Artificial intelligence depends on high-quality digital data. Without standardized whole slide images, even the most advanced AI algorithms cannot deliver reliable results.

Therefore, hospitals must first establish a robust digital pathology infrastructure before implementing AI applications.

A complete digital pathology workflow typically includes:

• High-resolution whole slide image acquisition
• Secure image storage and management
• Standardized pathology workflows
• Remote consultation capabilities
• AI-assisted image analysis
• Continuous quality control

Each step contributes to the overall accuracy and reliability of AI-assisted diagnosis.

KFBIO provides a comprehensive digital pathology ecosystem that supports every stage of this workflow. From slide scanning to AI integration, the platform enables laboratories to accelerate digital transformation while maintaining clinical quality and data security.

Why This Case Matters

The collaboration between KFBIO and Zhongshan Hospital demonstrates that successful pathology AI is no longer limited by expensive computing infrastructure. Instead, healthcare organizations can build efficient, secure, and scalable AI platforms using cost-effective computing resources while continuously improving model performance.

More importantly, the project reinforces an important lesson for the digital pathology industry. AI is only one component of a successful pathology ecosystem. High-quality imaging, standardized workflows, intelligent data management, and seamless system integration are equally essential.

This philosophy closely aligns with KFBIO’s vision of delivering an end-to-end digital pathology solution that empowers hospitals, research institutions, and laboratories worldwide.

Building a Trusted AI Infrastructure for Pathology

Artificial intelligence can only create clinical value when it is built on a reliable infrastructure. While AI algorithms often receive the most attention, the underlying computing platform determines how efficiently hospitals can train, deploy, and continuously improve their models.

To address this challenge, KFBIO and Zhongshan Hospital jointly established a trusted computing environment for pathology AI. The platform integrates every stage of the AI lifecycle, including data governance, model training, performance validation, clinical deployment, and continuous optimization. This closed-loop workflow enables AI models to evolve alongside real clinical practice rather than remain static after deployment.

Another important achievement was the use of domestic computing resources. By optimizing model training and inference, the platform delivered nearly 90% of the computing efficiency of an NVIDIA H100 GPU at approximately one-sixth of the cost. This approach significantly lowers the financial barrier to AI adoption while maintaining strong performance for large pathology models.

Beyond cost savings, the trusted computing environment enhances data security and operational reliability. Pathology data remains within the hospital’s controlled environment throughout training, inference, and model updates. As a result, hospitals can continuously improve AI performance while maintaining data privacy, traceability, and regulatory compliance.

For healthcare organizations planning long-term digital transformation, this type of infrastructure provides a sustainable foundation for future AI applications.

Clinical Application 1: Gastric Biopsy AI

One of the most successful applications in this project focuses on gastric biopsy diagnosis.

The research team continuously refined the AI model through multiple rounds of clinical validation. As the model evolved from Version 0.6 to Version 0.7, diagnostic performance improved significantly.

The updated model achieved a sensitivity of 98.99% for detecting low-grade intraepithelial neoplasia and more advanced lesions. At the same time, specificity increased to 99.56%. These improvements reduce the likelihood of missed lesions while maintaining excellent diagnostic precision.

More importantly, the latest model provides practical assistance during routine diagnosis. It can automatically identify suspicious regions, highlight potential lesions, and support structured pathology reporting. Instead of manually reviewing every tissue section, pathologists receive intelligent guidance that helps them focus on clinically significant findings.

This human-AI collaboration improves efficiency without replacing professional expertise. AI performs rapid preliminary analysis, while pathologists remain responsible for final clinical interpretation and diagnosis

Clinical Application 2: Cervical Cytology AI

Cervical cytology screening represents another important application of pathology AI.

Unlike gastric biopsy diagnosis, cervical cytology often involves reviewing large numbers of normal slides. This repetitive work consumes valuable time that experienced pathologists could otherwise spend on complex cases.

The AI-assisted cervical cytology system addresses this challenge by automatically identifying a large proportion of negative samples.

According to the project results, the system automatically classified more than 70% of negative cases while maintaining over 99.2% sensitivity for LSIL and higher-grade abnormalities.

This approach enables laboratories to streamline screening workflows without compromising patient safety.

Instead of replacing manual review, AI prioritizes slides that require closer examination. Consequently, pathologists can focus their expertise where it creates the greatest clinical value.

Measurable Clinical Benefits

The true value of pathology AI lies in measurable clinical outcomes rather than technical specifications alone. This project demonstrates how AI can improve diagnostic workflows while delivering tangible operational benefits for pathology laboratories.

After deploying the AI-assisted workflow, the pathology department achieved significant efficiency gains. Compared with conventional manual screening, AI-assisted slide review increased overall screening efficiency by approximately five times. In addition, diagnostic reports that previously required three pathologists could now be completed by two physicians. Report turnaround time was also reduced by around half a day, allowing clinicians to receive pathology results sooner.

These improvements extend beyond productivity. Faster reporting supports earlier clinical decision-making, while standardized AI-assisted review helps improve diagnostic consistency. At the same time, pathologists can devote more attention to challenging cases instead of spending valuable time on repetitive screening tasks.

For hospitals facing increasing workloads and limited pathology resources, this collaborative workflow offers a practical path toward sustainable growth.

Why End-to-End Digital Pathology Matters

Although AI algorithms often receive the spotlight, they represent only one component of a successful digital pathology strategy.

Every AI application depends on a complete digital pathology ecosystem. Without standardized image acquisition, secure data management, and efficient workflow integration, even the most advanced AI models cannot consistently deliver reliable clinical performance.

A successful AI-ready laboratory requires several key components:

• High-resolution whole slide image acquisition
• Reliable digital pathology scanners
• Intelligent image management
• Standardized laboratory workflows
• AI-assisted diagnostic tools
• Secure data storage and sharing
• Remote consultation capabilities
• Continuous quality control

When these elements work together, laboratories can establish a scalable digital pathology platform that supports routine diagnosis, education, scientific research, and future AI innovation.

How KFBIO Builds AI-Ready Digital Pathology Laboratories

KFBIO believes that digital transformation should begin with an integrated pathology ecosystem rather than isolated technologies.

For more than two decades, KFBIO has focused on delivering comprehensive digital pathology solutions that connect every stage of the pathology workflow. From slide scanning to AI-assisted diagnosis, our technologies help laboratories improve efficiency, standardize operations, and accelerate clinical collaboration.

High-Performance Digital Pathology Scanners

High-quality AI begins with high-quality images.

KFBIO’s Digital Pathology Scanners produce high-resolution whole slide images with excellent color fidelity, image consistency, and scanning efficiency. These scanners support routine clinical diagnosis, large-scale research projects, and AI model development by providing reliable digital image data.

Whether laboratories process dozens or thousands of slides each day, KFBIO offers scalable scanning solutions that meet different throughput requirements.

Whole Slide Imaging (WSI)

Whole Slide Imaging is the foundation of modern digital pathology.

By converting traditional glass slides into high-resolution digital images, WSI enables remote consultation, AI-assisted analysis, image sharing, education, and long-term data management.

KFBIO’s WSI solutions provide consistent image quality that supports both clinical practice and AI training, helping laboratories establish standardized digital workflows across multiple departments and institutions.

Digital Slide Management System

As digital slide volumes continue to grow, efficient image management becomes increasingly important.

KFBIO’s image management platform enables pathologists to organize, retrieve, review, and securely share whole slide images through a centralized digital environment.

Integrated workflow management also simplifies multidisciplinary collaboration, quality control, and case review while reducing administrative workload.

For organizations implementing AI, centralized image management creates a valuable data foundation for continuous model training and optimization.

AI-Ready Workflow Integration

Successful AI implementation requires more than software installation.

KFBIO’s end-to-end digital pathology ecosystem integrates seamlessly with AI-assisted applications, laboratory information systems (LIS), hospital information systems (HIS), and existing clinical workflows.

This integrated approach allows hospitals to adopt AI gradually while protecting existing infrastructure investments.

As new AI applications become available, laboratories can expand their digital pathology capabilities without rebuilding their entire workflow.

Looking Ahead

Artificial intelligence is rapidly evolving from an experimental technology into a trusted clinical partner. However, its long-term success depends on more than algorithm accuracy alone.

Hospitals also need reliable digital infrastructure, standardized workflows, secure data management, and high-quality whole slide imaging. Together, these elements create the foundation for sustainable AI adoption.

The collaboration between Jiangfeng Biotech and Zhongshan Hospital demonstrates how trusted computing infrastructure can accelerate pathology AI development. More importantly, it reinforces a broader industry trend: AI delivers the greatest clinical value when it operates within a complete digital pathology ecosystem.

At KFBIO, we remain committed to advancing digital pathology through continuous innovation. Our end-to-end solutions empower hospitals, laboratories, research institutes, and pharmaceutical organizations to build scalable, AI-ready pathology workflows that improve efficiency, enhance diagnostic confidence, and ultimately support better patient care worldwide.

Discover KFBIO’s Digital Pathology Solutions

Whether your organization is beginning its digital transformation or expanding an existing AI program, KFBIO provides the technologies needed to build a future-ready pathology laboratory.

Explore our complete portfolio of solutions, including:

• Digital Pathology Scanners
• Whole Slide Imaging (WSI)
• Digital Slide Management System
• AI-Ready Digital Pathology Platform
• Remote Consultation Solutions
• Research & Clinical Applications

Learn more at: https://kfbiopathology.com/